Tokyo, May 11, 2006 (JCN) - Eisai announced on May 10 that it has signed a joint research agreement with Nitto Denko. Under the agreement terms, the two companies will collaborate in developing a transdermal formulation (adhesive tape) of ARICEPT, an agent for treating Alzheimer's disease.
